BeOne Medicines (BEIGF) Interest Coverage Ratio (2015 - 2026)
BeOne Medicines (BEIGF) reported Interest Coverage Ratio of 7.6 for Q1 2026, up 379.25% year-over-year from 1.59 in Q1 2025, and up 379.25% quarter-over-quarter from 1.59 in Q1 2025.
BeOne Medicines (BEIGF) Interest Coverage Ratio (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 4 years of Interest Coverage Ratio data on file, last reported at 7.6 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 7.6, up 379.25% year-over-year; the trailing twelve-month figure through Mar 2026 was 20.86 (up 149.38% YoY), and the FY2025 annual result was 7.68, up 129.47% from the prior year.
- Interest Coverage Ratio advanced to 7.6 in Q1 2026 per BEIGF's latest filing, from 1.59 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 7.6 in Q1 2026 and troughed at 1.59 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | 11.79 |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 7.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.60 |
| Mar 31, 2025 | 1.59 |
| Sep 30, 2016 | -122.63 |
| Jun 30, 2016 | -174.67 |
| Mar 31, 2016 | -99.68 |
| Sep 30, 2015 | -46.64 |
| Jun 30, 2015 | -24.05 |
| Mar 31, 2015 | -36.75 |